Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report) shares fell 0.4% during trading on Monday . The stock traded as low as $20.40 and last traded at $20.40. 750 shares traded hands during trading, an increase of 321% from the average session volume of 178 shares. The stock had previously closed at $20.48.
Hikma Pharmaceuticals Stock Down 0.4%
The company has a debt-to-equity ratio of 0.33, a current ratio of 1.24 and a quick ratio of 0.72. The business’s 50-day moving average is $22.12 and its two-hundred day moving average is $24.38.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Read More
- Five stocks we like better than Hikma Pharmaceuticals
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport
- Consumer Staples Stocks, Explained
- Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png&h=45&w=95&zc=2){kind=logo}
